Depresyon ve Anksiyete Skorlarının Sigara Bırakma Tedavisi Üzerine Etkisi
Yükleniyor...
Tarih
2018
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Düzce Üniversitesi
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Amaç: Birçok psikiyatrik hastalıkta sigara içme prevalansıyüksektir. Bu çalışmanın amacı depresyon ve anksiyeteskorlarının sigara bırakma tedavisi üzerine etkisini değerlendirmektir. Gereçve Yöntem: 2016 yılında Sağlık Bilimleri ÜniversitesiKonya Eğitim ve Araştırma Hastanesi Sigara Bırakma Polikliniğine başvuranhastaların kayıtları retrospektif olarak değerlendirildi.Toplam 560 hasta kaydı araştırıldı. Kayıtlar Beck Depresyon Ölçeği (BDS), BeckAnksiyete Ölçeği (BAS), Fagerström Nikotin Bağımlılık Testi (FNDT),karbonmonoksit (CO) ölçümü ve sosyodemografik anket formundan oluşmaktadır.Hastalar, bırakma tedavisinin başlamasının ardından3. ayda telefonla aranmış ve sigarayı bırakıp bırakmadıkları sorulmuştur. Buçalışmaya toplam 560 hasta ile başlanmasına rağmen, 3 ay sonra telefonlaulaşılabilen 517 hasta ile çalışma tamamlandı.Bulgular: Sigarayı bırakanların yaşortalaması, bırakamayanlara göre daha yüksekti (p = 0.002). Aksine, sigarayıbırakamayan hastalarda ortalama CO düzeyleri (p lt;0.001) ve ortalama BDS (p lt;0.001) ve BAS (p lt;0.001) skorları anlamlı olarak yüksek bulundu.Hastaların diğer temel özellikleri gruplar arasındaistatistiksel olarak farklı değildi.Sonuç: Yüksek depresyon ve anksiyete skorları sigara bırakmatedavisinin başarı oranını azaltır. Bu hastaların anksiyete ve depresyonaçısından değerlendirilmeleri, sağlık profesyonellerinintıbbi tedavi ile birlikte psikososyal danışmanlık sağlaması ve gerektiğindepsikiyatristle konsülte edilmesi, bu hastalarda yüksek başarı elde etmek içinönemli basamaklardır.
Objective: Smoking prevalence ishigh in many psychiatric diseases. The aim of this study is to evaluatedepression and anxiety effect among smoking cessation treatment.Methods: Records of patients whoadmitted to the smoking cessation clinic in Health Sciences University, KonyaEducation and Research Hospital, in 2016 were retrospectively evaluated. Atotal of 560 patients’ records were investigated. Records consisted of Beck Depression Scale (BDS), Beck Anxiety Scale (BAS), FagerströmNicotine Dependence Test (FNDT), carbon-monoxide (CO) measurement, andsociodemographic questionnaire form. Patients were called by phone at the 3rdmonth following initiation of cessation treatment,and asked whether they quit smoking or not. Although this study was startedwith total 560 patients, the study was completed with 517 patients who could bereached by telephone 3 months later.Results: The mean age ofquitters was higher than the ones who could not(p=0.002). Contrary, the mean CO levels (p lt;0.001), and the mean BDS(p lt;0.001) and BAS (p lt;0.001) scores were significantly higher in patientswho failed to quit. Remaining characteristics of the patients were notstatistically different between groups.Conclusions: High depression andanxiety scores decreases the success rates of smoking cessation treatments.Assessment of these patients regarding anxiety and depression, providingpsychosocial counselling by health professionalstogether with the medical treatment, and consulting with a psychiatrist whenneeded are important steps for achieving high quit success in these patients.
Objective: Smoking prevalence ishigh in many psychiatric diseases. The aim of this study is to evaluatedepression and anxiety effect among smoking cessation treatment.Methods: Records of patients whoadmitted to the smoking cessation clinic in Health Sciences University, KonyaEducation and Research Hospital, in 2016 were retrospectively evaluated. Atotal of 560 patients’ records were investigated. Records consisted of Beck Depression Scale (BDS), Beck Anxiety Scale (BAS), FagerströmNicotine Dependence Test (FNDT), carbon-monoxide (CO) measurement, andsociodemographic questionnaire form. Patients were called by phone at the 3rdmonth following initiation of cessation treatment,and asked whether they quit smoking or not. Although this study was startedwith total 560 patients, the study was completed with 517 patients who could bereached by telephone 3 months later.Results: The mean age ofquitters was higher than the ones who could not(p=0.002). Contrary, the mean CO levels (p lt;0.001), and the mean BDS(p lt;0.001) and BAS (p lt;0.001) scores were significantly higher in patientswho failed to quit. Remaining characteristics of the patients were notstatistically different between groups.Conclusions: High depression andanxiety scores decreases the success rates of smoking cessation treatments.Assessment of these patients regarding anxiety and depression, providingpsychosocial counselling by health professionalstogether with the medical treatment, and consulting with a psychiatrist whenneeded are important steps for achieving high quit success in these patients.
Açıklama
Anahtar Kelimeler
Depresyon, Anksiyete, Sigara Bırakma tedavisi, Depression, Anxiety, Smoking Cessation Treatments
Kaynak
Konuralp Medical Journal
Konuralp Tip Dergisi
Konuralp Tip Dergisi
WoS Q Değeri
Scopus Q Değeri
Cilt
10
Sayı
2
